World Wires · story 32126 · unverified · 1 source(s)

Alterity Therapeutics to Present at the Canaccord Genuity Drug and Device Conference

MELBOURNE, Australia and SAN FRANCISCO, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a b

Open in the desk

Coverage

• Alterity Therapeutics to Present at the Canaccord Genuity Drug and Device Conference GlobeNewswire: public companies · tier D · clear net · 2026-10-09 11:05 UTC

What this site indexes